Skip to content
Clinical Trials – home
AustriaBack to Austria

Clinical trials in Klagenfurt am Wörthersee

58 clinical trials in Klagenfurt am Wörthersee, Austria across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Klagenfurt am Wörthersee at a glance
58
clinical trials
  • Paediatric trials0
  • Research sites2
Type of trial
Recruitment status
Quick filters

58 trials in Klagenfurt am Wörthersee

Open in trial search
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
  • Sponsor:Merz Therapeutics GmbH
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
  • Sponsor:Merz Therapeutics GmbH
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Medical University Of Graz
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Bio89-100
  • Sponsor:89bio Inc.
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Methyl (E,6S)-7-[[1-[2-(2-Ethylbutylamino)-2-Oxoethyl]-2-Oxopyridin-3-Yl]Amino]-6-[(3-Methylimidazole-4-Carbonyl)Amino]-7-Oxohept-2-Enoate
  • Sponsor:Dr. Falk Pharma GmbH
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Bempedoic Acid
  • Sponsor:Medical University Of Graz
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Sponsor:Glaxosmithkline Research & Development Limited

Other cities in Austria

The busiest research cities in the country

All 47 cities in Austria

Clinical research in Klagenfurt am Wörthersee

What the registry says about research in the country

01 Oncology Research

Groundbreaking studies focusing on hepatocellular carcinoma and non-small cell lung cancer, evaluating novel immunotherapy combinations and targeted treatments for improved patient outcomes.

  • Advanced liver cancer treatments
  • Lung cancer therapies
  • Pancreatic cancer interventions

Research includes innovative approaches combining immunotherapy with conventional treatments for various cancer types.

02 Cardiovascular Studies

Clinical trials investigating treatments for atrial fibrillation, myocardial infarction, and cardiac conditions, focusing on preventing strokes and improving heart function.

  • Stroke prevention therapies
  • Heart failure treatments
  • Cardiac imaging studies

Innovative approaches to treating and managing various cardiovascular conditions using both established and experimental medications.

03 Neurological Disorders

Studies examining new treatments for multiple sclerosis and migraine headaches, with emphasis on improving patient quality of life and disease management.

  • MS treatment innovations
  • Migraine prevention
  • Neurological therapeutics

Focus on developing targeted therapies for various neurological conditions affecting patients globally.

04 Respiratory Medicine

Research into interstitial lung diseases and community-acquired pneumonia, including COVID-19 related respiratory conditions.

  • Lung disease treatments
  • COVID-19 interventions
  • Respiratory function studies

Advanced therapeutic approaches for both acute and chronic respiratory conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).